“Development of Methods for Analysis and Interpretation of in vivo
Imaging of Prostate Cancer” for retrospective review of MRI exams from
patients with biopsy proven prostate cancer, protocol #20090554. A total of 30
consecutive patients, evaluated for radiation treatment from May 2012 through
November 2013 scanned on a Discovery MR750 3T MRI (GE, Waukesha, WI, USA) and 31
patients scanned from December 2008 through January 2014 on a Magnetom 3T Trio
(Siemens, Erlangen, Germany) were utilized. Patients’ clinical
characteristics are summarized in
fat saturation, were at identical spatial resolution: 0.7×0.7×2.5
mm3, 72 axial slices, no gap. Only T2FS sequence was analyzed for
Siemens. Imaging of the pelvis was acquired with parameters (
clinical applications of prostate MRI29 .